These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18953526)

  • 1. International symposium on genotoxic and carcinogenic thresholds.
    Bolt HM
    Arch Toxicol; 2008 Dec; 82(12):981-2. PubMed ID: 18953526
    [No Abstract]   [Full Text] [Related]  

  • 2. [New trends in carcinogenic thresholds---International Symposium on "Thresholds for Carcinogens and Mutagens"].
    Hori H; Kitagawa Y
    Shokuhin Eiseigaku Zasshi; 2006 Oct; 47(5):J308-10. PubMed ID: 17128878
    [No Abstract]   [Full Text] [Related]  

  • 3. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
    Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
    Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can one assess genotoxic and carcinogenic risk of asbestos without mentioning ingested fibres?
    Varga C
    Mutat Res; 2005 May; 572(1-2):173-4; author reply 175-6. PubMed ID: 15790501
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of potential carcinogenic dyes and intermediates on the basis of their genotoxicity].
    Barański B; Przybojewska B; Spiechowicz E; Wyszyńska K; Zimnicki J
    Med Pr; 1992; 43(6):469-77. PubMed ID: 1296106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic--an overview.
    Dybing E; O'Brien J; Renwick AG; Sanner T
    Toxicol Lett; 2008 Aug; 180(2):110-7. PubMed ID: 18584977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens.
    Kanode R; Chandra S; Sharma S
    Toxicol Mech Methods; 2017 Jun; 27(5):376-381. PubMed ID: 28325086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of thresholds on the risk assessment of carcinogens in food.
    Pratt I; Barlow S; Kleiner J; Larsen JC
    Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry viewpoint on thresholds for genotoxic carcinogens.
    Morelli MA
    Toxicol Pathol; 2000; 28(3):396-404. PubMed ID: 10862556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
    Brambilla G; Martelli A
    Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
    Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotoxicity of carcinogenic substances in humans and animals].
    Malaveille C; Bartsch H
    J Toxicol Clin Exp; 1989; 9(2 Pt 2):15-25. PubMed ID: 2677321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of genotoxic impurities in pharmaceutical development.
    Bercu JP; Dobo KL; Gocke E; McGovern TJ
    Int J Toxicol; 2009; 28(6):468-78. PubMed ID: 19966139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure.
    Hochstenbach K; van Leeuwen DM; Gottschalk RW; Gmuender H; Stølevik SB; Nygaard UC; Løvik M; Granum B; Namork E; van Loveren H; van Delft JH
    Mutat Res; 2012 Aug; 746(2):124-34. PubMed ID: 22269147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive resistance of Saccharomyces cerevisiae to chronic treatment with genotoxic and nongenotoxic carcinogens.
    Fahrig R; Fahrig B
    J Environ Pathol Toxicol Oncol; 1999; 18(2):103-8. PubMed ID: 15281221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
    Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
    Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.